Expert: Eliminating IP Protections for COVID-19 Vaccines Would Not Fix the Immediate Need for More Vaccinations Globally

Video

Gary Locke, former governor of Washington state, US Secretary of Commerce, and ambassador to China, discusses the World Trade Organization's TRIPS Council, which recently met to assess the elimination of IP protections for COVID-19 vaccines, diagnostics, and medical devices.

Pharmacy Times interviewed Gary Locke, former executive of King County, governor of Washington state, US Secretary of Commerce, and ambassador to China under the Obama administration, to discuss the World Trade Organization's TRIPS Council. The council convened on October 13 and 14 to assess a proposed waiver to the TRIPS Agreement that would eliminate IP protections for COVID-19 vaccines, diagnostics, and medical devices—potentially permanently.

During the discussion, Locke addressed why the misconception persists regarding the value of eliminating IP protections for COVID-19 vaccines in order to increase global vaccinations, investments that countries such as the United States could make that would be beneficial in the fight against the pandemic abroad, what some of the lasting ramifications of the elimination of IP protections for COVID-19 vaccines may be for US research and development, and what his hopes are for the future in relation to the world’s approach to fighting the spread of the coronavirus.

Related Videos
pharmacy oncology, Image Credit: © Konstantin Yuganov - stock.adobe.com
Mayo Clinic oncology pharmacy
Testicular cancer and prostate cancer concept. | Image Credit: kenchiro168 - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.